Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elena A. Grinishina"'
Autor:
Ochirbat Batbold, Larisa V. Yurchenko, Dmytro Butov, Mikola E Kovolev, Vika Borisova, Hanna Stepanenko, Nina I. Sokolenko, Elena A. Grinishina, Natalia D Prihoda, Ariungerel Tseveendorj, Alan A. Reid, Khaliunaa Baasanjav, Uyanga Batbold, Narantsetseg Damdinpurev, Tetyana Butova, Satria A. Prabowo, Munkhburam Sanjagdorj, John Lawson Stanford, Allen I Bain, Erkhemtsetseg Chunt, Cynthia Ann Stanford, Vichai Jirathitikal, Natalia I. Makeeva, Olga Arzhanova, Aldar S. Bourinbaiar, Peter Nyasulu, Yuri V Efremenko, Valeryi Kalashnikov, Marina G Tarakanovskaya, Otgonbayar Mijiddorj
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 18, Iss, Pp-(2020)
Objective: Immunotherapy of tuberculosis (TB) to shorten treatment duration represents an unmet medical need. Orally delivered, tableted TB vaccine (V7) containing heat-killed Mycobacterium vaccae (NCTC 11659) has been demonstrated in prior clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7acdac0dc919971d1ae6156f009f0b09
https://doi.org/10.1016/j.jctube.2019.100141
https://doi.org/10.1016/j.jctube.2019.100141
Autor:
Uyanga Batbold, Ochirbat Batbold, Dmytro O. Butov, Mikola E Kovolev, Ariungerel Tseveendorj, Aldar S. Bourinbaiar, Galyna A Kutsyna, Vichai Jirathitikal, Svetlana I Zaitzeva, Khaliunaa Baasanjav, Hanna Stepanenko, Erkhemtsetseg Chunt, Peter Nyasulu, Natalia I. Makeeva, Allen I Bain, Narantsetseg Damdinpurev, Tatyana S. Butova, Igor V Mospan, John L Rowe, Marina G Tarakanovskaya, Otgonbayar Mijiddorj, Munkhburam Sandagdorj, Volodymyr S. Pylypchuk, Elena A. Grinishina
Publikováno v:
Immunotherapy. 9(1)
Aim: Safer and shorter antituberculosis treatment (ATT) regimens represent the unmet medical need. Patients & methods: The patients were randomly assigned into two arms: the first (n = 137) received once-daily sublingual honey lozenge formulated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede61d0093f67aff2dff8ef7296170f6
https://pubmed.ncbi.nlm.nih.gov/27868466
https://pubmed.ncbi.nlm.nih.gov/27868466
Autor:
Larisa V. Yurchenko, Valery M. Frolov, Olga V. Arjanova, Svetlana I Zaitzeva, Olga A. Maksimenko, Galyna A Kutsyna, Anna L Stepanenko, Nina I. Sokolenko, Tatyana S. Butova, Elena A. Grinishina, Natalia D Prihoda, Vichai Jirathitikal, Dmitry A Butov, Aldar S. Bourinbaiar
Publikováno v:
Open Journal of Immunology. :50-55
reatment failed TB patients have very limited chances of survival. Open label trial of daily oral pill of V-5 Immunitor (V5) was conducted in 48 treatment-failed TB patients on palliative support consisting of isoniazid (H) and rifampicin (R). The su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f064cf0848c888022132a7a42176da1f
https://doi.org/10.4236/oji.2011.12006
https://doi.org/10.4236/oji.2011.12006